In quickly moving scientific developments over the past 24 hours, three separate labs that tested the Omicron (B.1.1.529) COVID-19 variant against vaccines reported significant immune escape based on reduced antibody...
A common strategy to make vaccines more powerful is to deliver them along with an adjuvant — a compound that stimulates the immune system to produce a stronger response. Researchers from MIT, the La Jolla Institute for...
About a year passed between COVID-19’s discovery and the creation of a vaccine. Why was malaria so much harder? The World Health Organization (WHO) recommended a broad rollout for a malaria vaccine after a pilot...
A top Pfizer executive says the company is hopeful that booster shots will provide sufficient protection against the Omicron variant — but has already envisioned a timeline for the development of a new vaccine if that’s...
New research at the University of Chicago has found differences in immune pathway activation to influenza infection between individuals of European and African genetic ancestry. Many of the genes that were associated...
New research by a team of University of Florida investigators, and others, provides evidence that host immunity drives evolution of the dengue virus. The work, published in Science, retrospectively analyzes two decades...
Using the same approach they recently used to create effective vaccine candidates against COVID-19 and respiratory syncytial virus (RSV), scientists are tackling another virus: the tick-borne Crimean-Congo hemorrhagic...
By coupling machine learning with whole genome sequencing, University of Pittsburgh School of Medicine and Carnegie Mellon University scientists greatly improved the quick detection of infectious disease outbreaks...
Alzheimer’s disease (AD) is the most common cause of dementia, impacting roughly 44 million people worldwide. In some nations, those numbers could triple in the next fifty years, and scientists are desperately...
A recent study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes — immune system cells also known as helper T cells — produced by people who received either of the two available messenger...